نتایج جستجو برای: peptide based vaccine

تعداد نتایج: 3159027  

Journal: :Pharmaceuticals 2023

Breast cancer is considered the second-leading after lung and most prevalent among women globally. Currently, immunotherapy via vaccine has gained great attention due to specific targeted immune cell activity that creates a potent response, thus providing long-lasting protection against disease. Despite peptides being very susceptible enzymatic degradation poor immunogenicity, they can be easil...

Journal: :Infekciâ i Immunitet 2021

Vaccination of the population is one most effective countermeasures in responding to pandemic caused by novel coronavirus infection. Therefore, scientists all over world have been working develop and safe vaccines. We developed a synthetic peptide vaccine, EpiVacCorona, against SARS-CoV-2 coronavirus, which suspension for intramuscular administration containing composition chemically synthesize...

2013
Daisuke Nobuoka Toshiaki Yoshikawa Yu Sawada Toshiyoshi Fujiwara Tetsuya Nakatsura

Immunotherapy is a potentially attractive treatment option for patients with hepatocellular carcinoma (HCC). We have reported that glypican-3 (GPC3) is an ideal target for anticancer immunotherapy against HCC because its expression is specifically detected in > 80% of HCCs, even during the early stages. Further, increased GPC3 expression is correlated with a poor prognosis. Based on results obt...

Journal: :Journal of immunology 1998
R E Toes E I van der Voort S P Schoenberger J W Drijfhout L van Bloois G Storm W M Kast R Offringa C J Melief

Synthetic peptide-based vaccines have been shown to induce potent protective and therapeutic T cell-mediated immunity in preclinical animal models and are now being evaluated in clinical phase I/II studies for their efficacy against tumors or infectious diseases. However, such vaccines might also specifically tolerize T cells causing enhanced tumor outgrowth, as shown by vaccination with two CT...

Journal: :Vaccine 2004
Connie L Finstad Chang Yi Wang Jacek Kowalski Meilun Zhang Ming Lie Li Xuan Mao Li Wei Guo Xia Maarten C Bosland Krishna K Murthy Alan M Walfield Wayne C Koff Timothy J Zamb

We have designed a peptide-based immunotherapeutic vaccine for treatment of androgen-responsive prostate cancer. The vaccine targets the luteinizing hormone-releasing hormone (LHRH) decapeptide that results in an androgen-deprivation immunotherapy. The design elements of the peptide immunogens are the LHRH peptide or B cell epitope synthetically linked to different promiscuous helper T cell (Th...

آرش‌کیا, آرش , رحیمی, آرین , رحیمی, رقیه , شاندیز, سیدعطا‌اله سادات , مهدوی, مهدی , میرزایی, امیر , نوربازرگان, حسن ,

Background: Human papilloma virus is a DNA virus from the papillomavirus family that is most prevalent in human cervical cancers and many studies showed the E6 and E7 proteins are present in the majority of cervical cancer cases. Development of universal HPV peptide-based vaccine with more serotypes coverage has considerable value. The aim of the study was to design a multi-epitope universal va...

Journal: :Bioinformation 2005
Pandjassarame Kangueane Meena Kishore Sakharkar

UNLABELLED The current challenge in synthetic vaccine design is the development of a methodology to identify and test short antigen peptides as potential T-cell epitopes. Recently, we described a HLA-peptide binding model (using structural properties) capable of predicting peptides binding to any HLA allele. Consequently, we have developed a web server named T-EPITOPE DESIGNER to facilitate HLA...

2016
Markus W. Löffler P. Anoop Chandran Karoline Laske Christopher Schroeder Irina Bonzheim Mathias Walzer Franz J. Hilke Nico Trautwein Daniel J. Kowalewski Heiko Schuster Marc Günder Viviana A. Carcamo Yañez Christopher Mohr Marc Sturm Huu-Phuc Nguyen Olaf Riess Peter Bauer Sven Nahnsen Silvio Nadalin Derek Zieker Jörg Glatzle Karolin Thiel Nicole Schneiderhan-Marra Stephan Clasen Hans Bösmüller Falko Fend Oliver Kohlbacher Cécile Gouttefangeas Stefan Stevanović Alfred Königsrainer Hans-Georg Rammensee

BACKGROUND & AIMS We report a novel experimental immunotherapeutic approach in a patient with metastatic intrahepatic cholangiocarcinoma. In the 5year course of the disease, the initial tumor mass, two local recurrences and a lung metastasis were surgically removed. Lacking alternative treatment options, aiming at the induction of anti-tumor T cells responses, we initiated a personalized multi-...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید